These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6861206)

  • 1. Protection of mice against influenza virus infection: enhancement of nonspecific cellular responses by Corynebacterium parvum.
    Mak NK; Schiltknecht E; Ada GL
    Cell Immunol; 1983 Jun; 78(2):314-25. PubMed ID: 6861206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humoral and cellular responses of mice to infection with a cold-adapted influenza A virus variant.
    Mak NK; Zhang YH; Ada GL; Tannock GA
    Infect Immun; 1982 Oct; 38(1):218-25. PubMed ID: 6982860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of natural killer cells during murine influenza virus infection.
    Leung KN; Ada GL
    Immunobiology; 1981; 160(3-4):352-66. PubMed ID: 7327615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus.
    Mak NK; Leung KN; Ada GL
    Scand J Immunol; 1982 Jun; 15(6):553-61. PubMed ID: 6181555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The adjuvant effect of Corynebacterium parvum: T-cell dependence of macrophage activation.
    Sljivić VS; Watson SR
    J Exp Med; 1977 Jan; 145(1):45-57. PubMed ID: 299769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of natural resistance to influenza virus in lipopolysaccharide-responsive and -nonresponsive mice by Propionibacterium acnes.
    Gangemi JD; Hightower JA; Jackson RA; Maher MH; Welsh MG; Sigel MM
    Infect Immun; 1983 Feb; 39(2):726-35. PubMed ID: 6832817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) suppresses the humoral and cell-mediated immune responses to influenza A virus without affecting cytolytic activity in the lung.
    Warren TK; Mitchell KA; Lawrence BP
    Toxicol Sci; 2000 Jul; 56(1):114-23. PubMed ID: 10869459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
    Storch E; Baumgartl D; Kirchner H
    Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of mice against mouse hepatitis virus by Corynebacterium parvum.
    Schindler L; Streissle G; Kirchner H
    Infect Immun; 1981 Jun; 32(3):1128-31. PubMed ID: 6166566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice.
    Wells MA; Albrecht P; Ennis FA
    J Immunol; 1981 Mar; 126(3):1036-41. PubMed ID: 6970211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage immunity to influenza virus: in vitro and in vivo studies.
    Bruinink A; Haller O
    Exp Cell Biol; 1979; 47(3):190-201. PubMed ID: 89051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
    Dimmock NJ; Beck S; McLain L
    J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses.
    Mak NK; Sweet C; Ada GL; Tannock GA
    Immunology; 1984 Feb; 51(2):407-16. PubMed ID: 6319274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
    Morgan DJ; McLain L; Dimmock NJ
    Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.
    Glasgow LA; Fischbach J; Bryant SM; Kern ER
    J Infect Dis; 1977 May; 135(5):763-70. PubMed ID: 192811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intracerebral administration of Corynebacterium parvum on the growth of brain tumors in mice.
    Kiya K; Toge T; Harada K; Uozumi T; Hattori T
    Gan; 1981 Jun; 72(3):446-50. PubMed ID: 7319201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of mice from lethal influenza by defective interfering virus: T cell responses.
    McLain L; Morgan DJ; Dimmock NJ
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():375-81. PubMed ID: 1371542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation and mobilization in nude mice by Corynebacterium parvum and pyran: a functional and histologic study.
    Stinnett JD; Majeski JA
    J Surg Oncol; 1980; 14(4):327-32. PubMed ID: 6969333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages.
    Neumann C; Macher E; Sorg C
    Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.